María de Jesús Gallardo-Luna
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
María de Jesús Gallardo-Luna has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Efraín Navarro-Olivos
Directorate of Teaching and Research, Institute of Public Health from Guanajuato State, Guanajuato, Guanajuato, México
14 shared publications - Nicolás Padilla-Raygoza
Department of Research and Technological Development, Directorate of Teaching and Research, Institute of Public Health from Guanajuato State, Mexico
13 shared publications - Francisco Javier Magos-Vázquez
Directorate of Health Services, Institute of Public Health from Guanajuato State, Guanajuato, Mexico
11 shared publications - Gilberto Flores-Vargas
Department of Research and Technological Development, Directorate of Teaching and Research, Institute of Public Health from Guanajuato State, Guanajuato, Mexico
11 shared publications - Daniel Alberto Díaz-Martínez
Directorate of Health Services, Institute of Public Health from Guanajuato State, Guanajuato, Mexico
8 shared publications - Elia Lara-Lona
Department of Medicine, University of Guanajuato, Leon, Mexico
5 shared publications
Latest Publications
- Open Access
- 21 February 2024
- Published by University of Guanajuato in Acta Universitaria
- Vol. 34, 1-13
Análisis de la evolución de la pandemia covid-19 en el estado de Guanajuato y México: un estudio ecológico de series en el tiempo
The SARS-CoV-2 emergency and the covid-19 pandemic are a global public health phenomenon. The objective of this study was to analyze the time trends of covid-19 pandemic in Guanajuato and México. For the analysis, the public database of the National Epidemiological Surveillance System was used to show the indicators of covid-19 (monthly) corresponding to the Institute of Public Health of the State of Guanajuato and the rest of Mexico. Online graphs were designed with the counts; for comparisons, the rate ratio in semi-annual periods was chosen. Guanajuato showed a better performance at the beginning of the pandemic, but in January 2021 this trend seems to reverse. In later months the curves tend to be more similar between Guanajuato and the rest of Mexico. The explanations for this phenomenon may be the coordination of local actions, the biology of the pandemic itself, or vaccination plans. La emergencia de SARS-CoV-2 y la pandemia por covid-19 son un fenómeno de salud pública global. El objetivo de este trabajo fue analizar la evolución de la pandemia covid-19 en Guanajuato y en México. Para esto, se utilizó la base de datos pública del Sistema Nacional de Vigilancia Epidemiológica a fin de mostrar los indicadores de covid-19 (mensualmente) correspondientes al Instituto de Salud Pública del Estado de Guanajuato y el resto de México. Con los conteos se diseñaron gráficas en línea, y para comparaciones se optó por la razón de tasas en periodos semestrales. Guanajuato mostró un mejor desempeño al inicio de la pandemia, pero en enero de 2021, esta tendencia parece revertirse. En meses posteriores, las curvas tienden a ser más semejantes entre Guanajuato y el resto de México. Las explicaciones a este fenómeno pueden ser la coordinación de las respuestas locales, variaciones de la evolución de la pandemia o esquemas de vacunación.
- 21 February 2024
- Published by University of Guanajuato in Acta Universitaria
- Vol. 34, 1-13
Open AccessAnálisis de la evolución de la pandemia covid-19 en el estado de Guanajuato y México: un estudio ecológico de series en el tiempo
The SARS-CoV-2 emergency and the covid-19 pandemic are a global public health phenomenon. The objective of this study was to analyze the time trends of covid-19 pandemic in Guanajuato and México. For the analysis, the public database of the National Epidemiological Surveillance System was used to show the indicators of covid-19 (monthly) corresponding to the Institute of Public Health of the State of Guanajuato and the rest of Mexico. Online graphs were designed with the counts; for comparisons, the rate ratio in semi-annual periods was chosen. Guanajuato showed a better performance at the beginning of the pandemic, but in January 2021 this trend seems to reverse. In later months the curves tend to be more similar between Guanajuato and the rest of Mexico. The explanations for this phenomenon may be the coordination of local actions, the biology of the pandemic itself, or vaccination plans. La emergencia de SARS-CoV-2 y la pandemia por covid-19 son un fenómeno de salud pública global. El objetivo de este trabajo fue analizar la evolución de la pandemia covid-19 en Guanajuato y en México. Para esto, se utilizó la base de datos pública del Sistema Nacional de Vigilancia Epidemiológica a fin de mostrar los indicadores de covid-19 (mensualmente) correspondientes al Instituto de Salud Pública del Estado de Guanajuato y el resto de México. Con los conteos se diseñaron gráficas en línea, y para comparaciones se optó por la razón de tasas en periodos semestrales. Guanajuato mostró un mejor desempeño al inicio de la pandemia, pero en enero de 2021, esta tendencia parece revertirse. En meses posteriores, las curvas tienden a ser más semejantes entre Guanajuato y el resto de México. Las explicaciones a este fenómeno pueden ser la coordinación de las respuestas locales, variaciones de la evolución de la pandemia o esquemas de vacunación.
- Open Access
- 6 September 2023
- Published by IntechOpen
SARS-CoV-2 (COVID-19) Variants in Mexico
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Due to the virus transmission and propagation since its origin, numerous mutations and variants have occurred. The concern relies on the ability to evade natural immunity and cause infections, even bypassing the immunity generated after the application of vaccines. The World Health Organization classified the variants into variants of interest (VOI) and variants of concern (VOC). From 2020 to 2021, the VOC variants were the alpha, beta, gamma, and delta types, currently adding the omicron variant. Onthe other hand, the VOI variants were the eta, iota, kappa, lambda, and mu types. The importance of their study leads to the problem of the possible generation of new waves of contagion, after their appearance, with a high possibility that the immunity known as herd achieved with some previous variant does not become effective.
- 6 September 2023
- Published by IntechOpen
Open AccessSARS-CoV-2 (COVID-19) Variants in Mexico
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Due to the virus transmission and propagation since its origin, numerous mutations and variants have occurred. The concern relies on the ability to evade natural immunity and cause infections, even bypassing the immunity generated after the application of vaccines. The World Health Organization classified the variants into variants of interest (VOI) and variants of concern (VOC). From 2020 to 2021, the VOC variants were the alpha, beta, gamma, and delta types, currently adding the omicron variant. Onthe other hand, the VOI variants were the eta, iota, kappa, lambda, and mu types. The importance of their study leads to the problem of the possible generation of new waves of contagion, after their appearance, with a high possibility that the immunity known as herd achieved with some previous variant does not become effective.
- Open Access
- 30 June 2023
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 16 (2) , 1237-1243
Analysis of Fatality among COVID-19 Cases in Mexican Pregnant Women: A Cross-sectional Study
Biomedical and Pharmacology Journal (BPJ) is an international, open access, peer reviewed, quarterly research journal.
- 30 June 2023
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 16 (2) , 1237-1243
Open AccessAnalysis of Fatality among COVID-19 Cases in Mexican Pregnant Women: A Cross-sectional Study
Biomedical and Pharmacology Journal (BPJ) is an international, open access, peer reviewed, quarterly research journal.
- Open Access
- 20 December 2022
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 15 (4) , 2251-2258
Relationship between Gestational Hypertension and High Birth Weight, in the State of Guanajuato, Mexico
Hypertensive disease is one of the main concerns during pregnancy. It is classified as gestational hypertension, preeclampsia, and eclampsia. The objective of this study was to analyze whether there is a relationship between gestational hypertension and high birth weight (≥3500 g) in newborns. It was designed a retrospective quantitative study, considering women admitted for obstetric resolution and their products treated in hospitals from Guanajuato State, Mexico, with hypertension developing after 20 weeks of pregnancy. The Chi-squared test was performed to show a relationship between gestational hypertension and preeclampsia-eclampsia with the newborn's birth weight. Then calculated the effect of gestational hypertension on birthweight by computing the corresponding Odds Ratios (OR). We also fitted a multivariate logistic regression model that included age group, marital status, number of previous pregnancies, and gestational age as covariates. It was computed the Pearson correlation and adjusted a linear regression model to identify the relationship between systolic and diastolic pressure with birthweight. The alpha value was fixed at .05 as a threshold for statistical significance. The number of reviewed registries was 1,675. For the variables age, gestational age at hospital admission, systolic and diastolic blood pressure, and birth weight of the products, there are differences between the groups of mothers (P<.05). For the logistic regression model just including gestational hypertension as covariable, the OR was 1.28 (95% CI=1.0 to 1.63). The gestational age plays a confounding role -other variables did not improve the model-. Systolic and diastolic blood pressure showed a statistically significant (P=0.2, P=0.048) low negative correlation (r=-0.07, r=-0.06) with birth weight for women with gestational hypertension. There is an effect between gestational hypertension and high birth weight, although the effect is confounded by gestational age at birth time. Linear regression between systolic-diastolic pressure and birthweight supports this association. The evidence is low and further studies are advisable.
- 20 December 2022
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 15 (4) , 2251-2258
Open AccessRelationship between Gestational Hypertension and High Birth Weight, in the State of Guanajuato, Mexico
Hypertensive disease is one of the main concerns during pregnancy. It is classified as gestational hypertension, preeclampsia, and eclampsia. The objective of this study was to analyze whether there is a relationship between gestational hypertension and high birth weight (≥3500 g) in newborns. It was designed a retrospective quantitative study, considering women admitted for obstetric resolution and their products treated in hospitals from Guanajuato State, Mexico, with hypertension developing after 20 weeks of pregnancy. The Chi-squared test was performed to show a relationship between gestational hypertension and preeclampsia-eclampsia with the newborn's birth weight. Then calculated the effect of gestational hypertension on birthweight by computing the corresponding Odds Ratios (OR). We also fitted a multivariate logistic regression model that included age group, marital status, number of previous pregnancies, and gestational age as covariates. It was computed the Pearson correlation and adjusted a linear regression model to identify the relationship between systolic and diastolic pressure with birthweight. The alpha value was fixed at .05 as a threshold for statistical significance. The number of reviewed registries was 1,675. For the variables age, gestational age at hospital admission, systolic and diastolic blood pressure, and birth weight of the products, there are differences between the groups of mothers (P<.05). For the logistic regression model just including gestational hypertension as covariable, the OR was 1.28 (95% CI=1.0 to 1.63). The gestational age plays a confounding role -other variables did not improve the model-. Systolic and diastolic blood pressure showed a statistically significant (P=0.2, P=0.048) low negative correlation (r=-0.07, r=-0.06) with birth weight for women with gestational hypertension. There is an effect between gestational hypertension and high birth weight, although the effect is confounded by gestational age at birth time. Linear regression between systolic-diastolic pressure and birthweight supports this association. The evidence is low and further studies are advisable.
- Open Access
Analysis of fatality among COVID-19 cases in Mexican pregnant women: a cross-sectional study
This study aims to analyze the fatality of cases confirmed by COVID-19 among pregnant women in Mexico. It is a cross-sectional and analytical study. We used the registries from pregnant women available in the open database of the National Epidemiological Surveillance System from the General Directorate of Epidemiology. We showed descriptive statistics for all the variables. A suspected case of COVID-19 is any person who presented the following signs and symptoms: fever, headache, cough, and others. A confirmed case is any suspected case with a positive RT-PCR test result. We computed OR and 95% confidence intervals to estimate the effect of independent variables on dying from COVID-19. Also, it was calculated the Case Fatality Ratio (CFR) among pregnant women. The alpha value was fixed at 0.05 as a threshold to show statistical significance. The CFR was 1.09%. For confirmed cases, the average age among those who died was higher than among those who did not die (P <0.05). The average time between the onset of symptoms and registration in the system was higher for those who died (P <0.05). Among the deceased, 76.97% had pneumonia. For the 40-49 years age group, the effect on death was statistically significant (OR 4.97, CI95% 1.77 – 17.85). Outpatient care had a protective effect on dying (OR 0.04, CI95% 0.02 – 0.09). Pneumonia was highly associated with death (OR 8.68, CI95% 5.72 – 13.6). Co-morbidities did not affect dying while considering them in a multivariable logistic regression model. Among pregnant women, smoking has little effect on death by COVID-19. The CFR was low compared with the rest of the Mexican population. The co-morbidities had a low prevalence among pregnant women. Since the reproductive age span is young age, pregnant women have two protective factors for COVID-19 detected so far: being young and woman.
Open AccessAnalysis of fatality among COVID-19 cases in Mexican pregnant women: a cross-sectional study
This study aims to analyze the fatality of cases confirmed by COVID-19 among pregnant women in Mexico. It is a cross-sectional and analytical study. We used the registries from pregnant women available in the open database of the National Epidemiological Surveillance System from the General Directorate of Epidemiology. We showed descriptive statistics for all the variables. A suspected case of COVID-19 is any person who presented the following signs and symptoms: fever, headache, cough, and others. A confirmed case is any suspected case with a positive RT-PCR test result. We computed OR and 95% confidence intervals to estimate the effect of independent variables on dying from COVID-19. Also, it was calculated the Case Fatality Ratio (CFR) among pregnant women. The alpha value was fixed at 0.05 as a threshold to show statistical significance. The CFR was 1.09%. For confirmed cases, the average age among those who died was higher than among those who did not die (P <0.05). The average time between the onset of symptoms and registration in the system was higher for those who died (P <0.05). Among the deceased, 76.97% had pneumonia. For the 40-49 years age group, the effect on death was statistically significant (OR 4.97, CI95% 1.77 – 17.85). Outpatient care had a protective effect on dying (OR 0.04, CI95% 0.02 – 0.09). Pneumonia was highly associated with death (OR 8.68, CI95% 5.72 – 13.6). Co-morbidities did not affect dying while considering them in a multivariable logistic regression model. Among pregnant women, smoking has little effect on death by COVID-19. The CFR was low compared with the rest of the Mexican population. The co-morbidities had a low prevalence among pregnant women. Since the reproductive age span is young age, pregnant women have two protective factors for COVID-19 detected so far: being young and woman.
- Open Access
- 29 September 2022
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 15 (3) , 1427-1436
Seroprevalence of SARS-CoV-2 in Health-care Personnel from the State of Guanajuato, Mexico: A Cross-Sectional Study
Background. Guanajuato state in Mexico has high frequency of confirmed cases of COVID-19. Health-care workers are the most exposed to contagion due to contact with patients infected by SARS-CoV-2. The objective was to know the seroprevalence of antibodies (IgG) anti-SARS-CoV-2 in health-care workers from Secretary of Health from Guanajuato State. Material and methods. It was a cross-sectional, retrolective study, using database from the ENSERO-COVID program. It was recollected data about exposure in work and in community by contact with confirmed cases of COVID-19. The anti-SARS-CoV IgG antibody titer was determined, considering 1.4 or higher as positive. It used Chi squared test to show relationship between variables, Z for two proportions to test hypotheses and logistic regression for show the effect of exposure and test positive for antibodies. Results. 4,047 registries were reviewed, 376 (9.29%) were positive for the presence of SARS-CoV-2 antibodies. There is an association between the type of work unit (type determined by hospitalizing COVID-19 patients or not) with seropositivity (P <0.05). There was no effect of performance areas to be seropositive. Community exposure had an effect on being seropositive OR = 1.44 (1.17 - 1.79). Training in the proper use of personal protective equipment had a protective effect on being seropositive with OR = 0.79 (0.64 -0.99). Conclusion. Exposure in the community to a confirmed case to SARS-CoV-2 is found to have a significant association with the presence of anti-SARS-CoV-2 antibodies. Training in the proper use of personal protection equipment is a protector against SARS-CoV-2 infection. There is a significant association between the type of unit and the presence of anti-SARS-CoV-2 antibodies. Given the increase in the number of confirmed cases of SARS-CoV-2, it is vitally important that health workers adequately protect themselves both at the community and workplace level.
- 29 September 2022
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 15 (3) , 1427-1436
Open AccessSeroprevalence of SARS-CoV-2 in Health-care Personnel from the State of Guanajuato, Mexico: A Cross-Sectional Study
Background. Guanajuato state in Mexico has high frequency of confirmed cases of COVID-19. Health-care workers are the most exposed to contagion due to contact with patients infected by SARS-CoV-2. The objective was to know the seroprevalence of antibodies (IgG) anti-SARS-CoV-2 in health-care workers from Secretary of Health from Guanajuato State. Material and methods. It was a cross-sectional, retrolective study, using database from the ENSERO-COVID program. It was recollected data about exposure in work and in community by contact with confirmed cases of COVID-19. The anti-SARS-CoV IgG antibody titer was determined, considering 1.4 or higher as positive. It used Chi squared test to show relationship between variables, Z for two proportions to test hypotheses and logistic regression for show the effect of exposure and test positive for antibodies. Results. 4,047 registries were reviewed, 376 (9.29%) were positive for the presence of SARS-CoV-2 antibodies. There is an association between the type of work unit (type determined by hospitalizing COVID-19 patients or not) with seropositivity (P <0.05). There was no effect of performance areas to be seropositive. Community exposure had an effect on being seropositive OR = 1.44 (1.17 - 1.79). Training in the proper use of personal protective equipment had a protective effect on being seropositive with OR = 0.79 (0.64 -0.99). Conclusion. Exposure in the community to a confirmed case to SARS-CoV-2 is found to have a significant association with the presence of anti-SARS-CoV-2 antibodies. Training in the proper use of personal protection equipment is a protector against SARS-CoV-2 infection. There is a significant association between the type of unit and the presence of anti-SARS-CoV-2 antibodies. Given the increase in the number of confirmed cases of SARS-CoV-2, it is vitally important that health workers adequately protect themselves both at the community and workplace level.
- Open Access
- 30 June 2022
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 15 (2) , 993-1003
Reactivity and Safety of BioNTech/Pfizer® Vaccine Anti-SARS-CoV-2, in Health Personnel from the Mexican State of Guanajuato
The Severe Acute Respiratory Syndrome Coronavirus 2, first detected in Wuhan, China, in 2019, had spread all over the world. It has caused the COVID-19 pandemic. Nowadays, there are effective and safe vaccines proven against this virus. The goal of this study was to verify it among health-care workers from the Institute of Public Health from Guanajuato State who received the BioNTech/Pfizer vaccine. For this purpose, we designed a quantitative cross-sectional study. The database was obtained from a previous strategy program by the Institute of Public Health from Guanajuato State called ENSERO-COVID. The available data consisted of two chemiluminescence measures of the IgG anti-Spike antibodies after one and six months of the BioNTech/Pfizer vaccine two doses application. The survey also included self-reported reactions to this vaccine. Frequency tables are presented for descriptive purposes. We performed the chi-square test, the z test for proportions, and the t-test for comparisons. Also, two linear regression models were fitted between the first and second chemiluminescence levels stratifying by prior infection by SARS-CoV-2. The database consisted of 177 records. Of them, 45 (25.4%) were positive for SARS-CoV-2 before vaccination. Only one person did not react to the two doses of vaccine application. Most of the self-reported reactions ceased in a short period -less than three days-. The differences observed, regarding chemiluminescence levels, between those with and without prior infection by SARS-CoV-2 were not statistically significant. More analyses are required to assess the long-term effects of the BioNTech/Pfizer ® vaccine.
- 30 June 2022
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 15 (2) , 993-1003
Open AccessReactivity and Safety of BioNTech/Pfizer® Vaccine Anti-SARS-CoV-2, in Health Personnel from the Mexican State of Guanajuato
The Severe Acute Respiratory Syndrome Coronavirus 2, first detected in Wuhan, China, in 2019, had spread all over the world. It has caused the COVID-19 pandemic. Nowadays, there are effective and safe vaccines proven against this virus. The goal of this study was to verify it among health-care workers from the Institute of Public Health from Guanajuato State who received the BioNTech/Pfizer vaccine. For this purpose, we designed a quantitative cross-sectional study. The database was obtained from a previous strategy program by the Institute of Public Health from Guanajuato State called ENSERO-COVID. The available data consisted of two chemiluminescence measures of the IgG anti-Spike antibodies after one and six months of the BioNTech/Pfizer vaccine two doses application. The survey also included self-reported reactions to this vaccine. Frequency tables are presented for descriptive purposes. We performed the chi-square test, the z test for proportions, and the t-test for comparisons. Also, two linear regression models were fitted between the first and second chemiluminescence levels stratifying by prior infection by SARS-CoV-2. The database consisted of 177 records. Of them, 45 (25.4%) were positive for SARS-CoV-2 before vaccination. Only one person did not react to the two doses of vaccine application. Most of the self-reported reactions ceased in a short period -less than three days-. The differences observed, regarding chemiluminescence levels, between those with and without prior infection by SARS-CoV-2 were not statistically significant. More analyses are required to assess the long-term effects of the BioNTech/Pfizer ® vaccine.
- Open Access
- 23 June 2022
- Published by Sciencedomain International in Journal of Advances in Medicine and Medical Research
- p. 234-244
Effect of Social Determinants on Knowledge and Barriers to the use of Preventive Measures against SARS-CoV-2 Infection
Aims: To analyze the effect of social determinants on knowledge and barriers to using protective measures against SARS-CoV-2 infection. Study Design: Analytical cross-sectional study. Place and Duration of Study: Sample: Institute of Public Health Staff from Guanajuato State and their relatives, between June 2009 and July 2010. Methodology: As social determinants, data on age, sex, marital status, and academic degree were obtained. Knowledge and barriers were quantified by a purposely designed questionnaire, with construct validity and reliability of 0.70 (95% CI 0.61 - 0.78) (Cohen's Kappa). The survey was sent by e-mail to the Institute workers. They were allowed to invite their relatives aged 18 or over. Results: 1,414 questionnaires were obtained with a participation rate of 9.49%. The age ranged from 18 to 75 years, with a mean of 39.51 ± 10.02 years. Women predominated with 69.59%, persons with married status with 51.49%, and academic degrees with 55.80%. All participants showed adequate knowledge. There were internal and external barriers. The only one that showed a relationship and effect with social determinants was that the protective measures were expensive (with gender, X2= 10.35 df 1 P=.001), OR=0.65 (95% CI 0.50 – 0.85); for the rest of the social determinants (age, marital status, and academic degree) they did not show any relationship or effect. Conclusion: All participants had adequate knowledge and a few barriers to using the preventive measures against SARS-CoV-2.
- 23 June 2022
- Published by Sciencedomain International in Journal of Advances in Medicine and Medical Research
- p. 234-244
Open AccessEffect of Social Determinants on Knowledge and Barriers to the use of Preventive Measures against SARS-CoV-2 Infection
Aims: To analyze the effect of social determinants on knowledge and barriers to using protective measures against SARS-CoV-2 infection. Study Design: Analytical cross-sectional study. Place and Duration of Study: Sample: Institute of Public Health Staff from Guanajuato State and their relatives, between June 2009 and July 2010. Methodology: As social determinants, data on age, sex, marital status, and academic degree were obtained. Knowledge and barriers were quantified by a purposely designed questionnaire, with construct validity and reliability of 0.70 (95% CI 0.61 - 0.78) (Cohen's Kappa). The survey was sent by e-mail to the Institute workers. They were allowed to invite their relatives aged 18 or over. Results: 1,414 questionnaires were obtained with a participation rate of 9.49%. The age ranged from 18 to 75 years, with a mean of 39.51 ± 10.02 years. Women predominated with 69.59%, persons with married status with 51.49%, and academic degrees with 55.80%. All participants showed adequate knowledge. There were internal and external barriers. The only one that showed a relationship and effect with social determinants was that the protective measures were expensive (with gender, X2= 10.35 df 1 P=.001), OR=0.65 (95% CI 0.50 – 0.85); for the rest of the social determinants (age, marital status, and academic degree) they did not show any relationship or effect. Conclusion: All participants had adequate knowledge and a few barriers to using the preventive measures against SARS-CoV-2.
- 7 March 2022
- Published by Sciencedomain International
- p. 9-17
Pneumonia and COVID-19 in Mexico
In this chapter, we present a review of the SARS-CoV-2 and COVID-19 presence among the Mexican population. We also show the effect of pneumonia in people with COVID-19 whose outcome was fatal so far. For all age groups, pneumonia is one of the leading causes of death among patients diagnosed with COVID-19. It is more frequent because SARS-CoV-2 uses the ACE receptor to enter epithelial cells primarily in the respiratory tract. All ages, from the Mexican population, had pneumonia as a significant risk factor to die due to COVID-19. In the Mexican population under 19 years of age, a positive correlation and linear relationship between pneumonia and Case Fatality Ratio r=0.79, CFR(%)=0.02 + 0.29 cases with pneumonia(%), t=0.68, P-value=.0001. In conclusion, pneumonia is a leading cause of death in patients with COVID-19.
- 7 March 2022
- Published by Sciencedomain International
- p. 9-17
Pneumonia and COVID-19 in Mexico
In this chapter, we present a review of the SARS-CoV-2 and COVID-19 presence among the Mexican population. We also show the effect of pneumonia in people with COVID-19 whose outcome was fatal so far. For all age groups, pneumonia is one of the leading causes of death among patients diagnosed with COVID-19. It is more frequent because SARS-CoV-2 uses the ACE receptor to enter epithelial cells primarily in the respiratory tract. All ages, from the Mexican population, had pneumonia as a significant risk factor to die due to COVID-19. In the Mexican population under 19 years of age, a positive correlation and linear relationship between pneumonia and Case Fatality Ratio r=0.79, CFR(%)=0.02 + 0.29 cases with pneumonia(%), t=0.68, P-value=.0001. In conclusion, pneumonia is a leading cause of death in patients with COVID-19.